Additionally, analysis of the National Cancer Institute’s REMBRANDT (Repository of Molecular Brain Neoplasia Data) database [28] showed that increased RelB expression strongly correlates with poor survival in glioma patients, whereas low RelB expression is associated with increased survival (Supplemental Figure S1). This evidence concerns the gene RELB and glioma.